Effects of tyrosine kinase inhibitor, genistein, and phosphotyrosine-phosphatase inhibitor, orthovanadate, on Ca(2+)-free contraction of uterine smooth muscle of the rat

Gen Pharmacol. 1994 Dec;25(8):1673-7. doi: 10.1016/0306-3623(94)90371-9.

Abstract

1. The effects of a protein-tyrosine kinase inhibitor, genistein, and a protein-tyrosine phosphatase inhibitor, orthovanadate, were tested on the Ca(2+)-free contraction of the estrogen-dominated rat, which has been proved to be induced mainly via protein kinase C entirely independently of Ca2+. 2. Genistein (30 microM) significantly inhibited the contraction indicating participation of tyrosine kinase activity in the contraction. 3. Orthovanadate caused contraction concentration-dependently and augmented the Ca(2+)-free contraction at concentrations of more than 1 microM. The contraction by orthovanadate was not inhibited so significantly by genistein (30 microM). 4. Possible participation of tyrosine kinase activity in Ca(2+)-free contraction is discussed in addition to the formerly reported participation of protein kinase C.

MeSH terms

  • Animals
  • Calcium / physiology
  • Drug Interactions
  • Female
  • Genistein
  • In Vitro Techniques
  • Isoflavones / pharmacology
  • Oxytocin / pharmacology*
  • Protein Tyrosine Phosphatases / antagonists & inhibitors
  • Protein Tyrosine Phosphatases / physiology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / physiology*
  • Rats
  • Uterine Contraction / drug effects*
  • Vanadates / pharmacology*

Substances

  • Isoflavones
  • Vanadates
  • Oxytocin
  • Genistein
  • Protein-Tyrosine Kinases
  • Protein Tyrosine Phosphatases
  • Calcium